Hepatitis: Screening and Testing Methods

The disclosure of hepatitis infection (HV) has prompted the advancement of serological tests for the discovery of counteracting agent to this newfound infection. Gatherings at more serious danger of obtaining HV contamination incorporate intravenous medication clients, haemodialysis patients, haemophiliacs and blood transfusion beneficiaries. The screening of blood givers for hostile to HV has incredibly diminished the rate of post-transfusion hepatitis. One of the real issues with HV disease is the advancement of endless hepatitis in 50 to 60% of cases, which could prompt cirrhosis and hepatocellular carcinoma.

  • Serological assays for detection of HV infection
  • Molecular assays for the detection of HV infection
  • Quantitation of HV RNA
  • Genotyping of HV isolates

Related Conference of Hepatitis: Screening and Testing Methods

April 08-09, 2026

14th World Gastro Summit

London, UK
June 18-19, 2026

9th International Congress on Viral Hepatitis

Paris, France
August 03-04, 2026

21st Euro-Global Gastroenterology Conference

London, UK
September 29-30, 2026

7th Global Summit on Earth Science and Climate Change

Aix-en-Provence, France

Hepatitis: Screening and Testing Methods Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in